Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $14,972 - $19,447
-573 Reduced 7.2%
7,387 $212,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $8,503 - $9,940
-265 Reduced 3.22%
7,960 $264,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $37,853 - $43,795
1,048 Added 14.6%
8,225 $301,000
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $748 - $974
19 Added 0.27%
7,177 $292,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $1,419 - $1,853
34 Added 0.48%
7,158 $366,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $9,102 - $11,111
-208 Reduced 2.84%
7,124 $312,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $116,231 - $137,814
2,498 Added 51.68%
7,332 $384,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $122,198 - $151,418
-2,671 Reduced 35.59%
4,834 $250,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $101,771 - $150,858
2,463 Added 48.85%
7,505 $443,000
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $212,107 - $272,469
-5,404 Reduced 51.73%
5,042 $217,000
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $21,438 - $24,285
-597 Reduced 5.41%
10,446 $409,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $23,242 - $26,212
-694 Reduced 5.91%
11,043 $400,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $100,276 - $127,509
2,996 Added 34.28%
11,737 $432,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $16,541 - $19,407
521 Added 6.34%
8,741 $321,000
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $2,018 - $2,448
-67 Reduced 0.81%
8,220 $269,000
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $1,811 - $2,587
67 Added 0.82%
8,287 $270,000
Q4 2019

Feb 21, 2020

BUY
$32.92 - $37.36 $270,602 - $307,099
8,220 New
8,220 $322,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kerntke Otto Mc Glone Wealth Management Group Portfolio

Follow Kerntke Otto Mc Glone Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerntke Otto Mc Glone Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Kerntke Otto Mc Glone Wealth Management Group with notifications on news.